Back to Journals » Clinical Ophthalmology » Volume 13
Corrigendum
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,749 | Dovepress* | 5,537+ | 1,473 | 7,010 | |
PubMed Central* | 212 | 81 | 293 | ||
Totals | 5,749 | 1,554 | 7,303 | ||
*Since 24 January 2019 |
View citations on PubMed Central and Google Scholar